Top compounds associated with response to IFFO2


Feature Type Standardized
Nominal ANOVA
mRNA PL-DI CTRPv2 pan-cancer AAC -0.064 0.05
mRNA CCT036477 CTRPv2 pan-cancer AAC -0.068 0.05
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.06
mRNA OSI-930 CTRPv2 pan-cancer AAC -0.072 0.06
mRNA fingolimod CTRPv2 pan-cancer AAC -0.071 0.06
mRNA erismodegib CTRPv2 pan-cancer AAC -0.075 0.06
mRNA Bortezomib gCSI pan-cancer AAC 0.13 0.06
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.066 0.06
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.064 0.06
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.069 0.06
Download CSV